Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.
Nakamura N, Yoshida K, Tsuda R, Murata M, Yamaguchi T, Suwa K, Ichimura M, Tsuneyama K, Matsuzaki K, Nakano T, Hirohara J, Seki T, Okazaki K, Gershwin ME, Naganuma M.
Nakamura N, et al. Among authors: hirohara j.
Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1480-1492. doi: 10.52586/5042.
Front Biosci (Landmark Ed). 2021.
PMID: 34994163
Free article.